Two distinct patterns of immune recovery inflammatory syndrome (IRIS) are recognized, paradoxical and unmasking IRIS. Here we raise some concerns regarding the first case of neuroPCM-IRIS published to date, as recently proposed by Almeida and Roza (Mycopathologia 177:137–141, 2017) for a patient originally described by Silva-Vergara et al. (Mycopathologia 182:393–396, 2014), taking in account the different case definitions for IRIS and the cases of neuroparacoccidioidomycosis already described in the literature. We are concerned that data from the case report have been misinterpreted and that no regard has been given to the possibility that the development of manifestations of neuroPCM after starting antiretroviral therapy and antifungal treatments could represent the predicted course of a missed neuroPCM diagnosis at presentation whose treatment failed. We hypothesize that diagnosis of the neuroPCM would not have been missed if careful screening for opportunistic infection of the central nervous system was performed prior to antiretroviral therapy initiation. Currently, there is no definitive diagnostic test for IRIS and diagnostic suspicion, as well as its management, are based on image studies and non-specific clinical signs and symptoms of inflammation. IRIS remains a diagnosis of exclusion, after considering drug toxicity, microbiologic treatment failure and the expected course of newly or previously diagnosed opportunistic infections.
Paradoxical IRIS Unmasking IRIS Paracoccidioidomycosis HIV
This is a preview of subscription content, log in to check access.
Compliance with Ethical Standards
Conflict of interest
The authors declare that they have no conflict of interest.
There was no research involving human participants or animals.
French MA. HIV/AIDS: immune reconstitution inflammatory syndrome: a reappraisal. Clin Infect Dis. 2009;48:101–7.CrossRefPubMedGoogle Scholar
Singh N, Perfect JR. Immune reconstitution syndrome associated with opportunistic mycoses. Lancet Infect Dis. 2007;7:395–401.CrossRefPubMedGoogle Scholar
Haddow LJ, Colebunders R, Meintjes G, et al. Cryptococcal immune reconstitution inflammatory syndrome in HIV infected individual: proposed clinical case definitions. Lancet Infect Dis. 2010;10:791–802.CrossRefPubMedPubMedCentralGoogle Scholar
Silva-Vergara ML, Rocha IH, Vasconcelos RR, et al. Central nervous system paracoccidioidomycosis in an AIDS patient: case report. Mycopathologia. 2014;177:137–41.CrossRefPubMedGoogle Scholar
de Almeida SM, Roza TH. HIV immune recovery inflammatory syndrome and central nervous system paracoccidiodomycosis. Mycopathologia. 2017;182:393–6.CrossRefPubMedGoogle Scholar
Shelburne ISA, Hamill RJ, Rodriguez-Barradas MC, et al. Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine. 2002;81:213–27.CrossRefPubMedGoogle Scholar
Robertson J, Meier M, Wall J, et al. Immune reconstitution syndrome in HIV: validating a case definition and identifying clinical predictors in persons initiating antiretroviral therapy. Clin Infect Dis. 2006;42:1639–46.CrossRefPubMedGoogle Scholar
de Almeida SM, Queiroz-Telles F, Teive HA, et al. Central nervous system paracoccidioidomycosis: clinical features and laboratorial findings. J Infect. 2004;48:193–8.CrossRefPubMedGoogle Scholar
Ma Q, Okusanya OO, Smith PF, et al. Pharmacokinetic drug interactions with nonnucleoside reverse transcriptase inhibitors. Expert Opin Drug Metab Toxicol. 2005;1:473–85.CrossRefPubMedGoogle Scholar
Walker NF, Scriven J, Meintjes G, et al. Immune reconstitution inflammatory syndrome in HIV-infected patients. HIV AIDS. 2015;7:49–64.CrossRefGoogle Scholar
Davies MA, Meintjes G. Assessing the contribution of the immune reconstitution inflammatory syndrome to mortality in developing country antiretroviral therapy programs. Clin Infect Dis. 2009;49:973–5.CrossRefPubMedPubMedCentralGoogle Scholar
Morejón KM, Machado AA, Martinez R. Paracoccidioidomycosis in patients infected with and not infected with human immunodeficiency virus: a case-control study. Am J Trop Med Hyg. 2009;80:359–66.PubMedCrossRefGoogle Scholar
Hutzler RU, Brussi MLP, Capitani CM, et al. Acometimento neurológico da paracoccidioidomicose avaliado pela tomografia computadorizada de crânio [in Portuguese]. Rev Paul Med. 1985;103:243–4.PubMedGoogle Scholar
Gasparetto EL, Liu CB, de Carvalho Neto A, et al. Central nervous system paracoccidioidomycosis: imaging findings in 17 cases. J Comput Assist Tomogr. 2003;27:12–7.CrossRefPubMedGoogle Scholar
Pedroso VS, Vilela Mde C, Pedroso ER, et al. Paracoccidioidomycosis compromising the central nervous system: a systematic review of the literature [in Portuguese]. Rev Soc Bras Med Trop. 2009;42:691–7.CrossRefPubMedGoogle Scholar
Finamor LP, Muccioli C, Martins MC, et al. Ocular and central nervous system paracoccidioidomycosis in a pregnant woman with acquired immunodeficiency syndrome. Am J Ophthalmol. 2002;134:456–9.CrossRefPubMedGoogle Scholar
Guimarães JCA, Bortoliero AI, Bonametti AM, et al. Infecção oportunista do sistema nervoso central por Paracoccidioides brasiliensis: relato do caso [abstract no 114]. Rev Soc Bras Med Trop. 1991;24:30–1.Google Scholar
Colombo AL, Junior GT, Lotfi CJ et al. Paracoccidioidomicose disseminada em pacientes com AIDS (achado de necropsia) [abstract no 42]. In: Program and abstracts of the 26th congresso da sociedade Brasileira de medicina tropical (São Paulo). São Paulo: Sociedade Brasileira de Medicina Tropical; 1989.Google Scholar
Meintjes G, Lawn SD, Scano F, et al. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis. 2008;8:516–23.CrossRefPubMedPubMedCentralGoogle Scholar